LCN2 and breast carcinoma: Their meta-analysis shows that high NGAL levels in biological fluids, such as serum and urine, could be useful to predict disease-free survival for patients with colorectal and breast cancer, but its prognostic and diagnostic accuracy remains uncertain for other human tumors, including pancreatic, thyroid, liver, lung, esophageal, oral, and kidney tumors [47].